Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-011288
Filing Date
2019-04-26
Accepted
2019-04-26 19:56:48
Documents
2
Period of Report
2019-04-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1634
2 EX-24 DOCUMENT attachment1.htm EX-24 4096
  Complete submission text file 0000899243-19-011288.txt   7207
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20451 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address
Kelley Lynne E (Reporting) CIK: 0001667584 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38295 | Film No.: 19773379